Hints and tips:
...jfk@ft.com Twitter: @JFK_America Letter in response to this article: How Biden’s pick tempers Wall Street’s appetite / From Mark Zashin, Short Hills, NJ, US...
...The pharmaceutical and healthcare sectors have been among the most active with $479bn worth of transactions announced....
...It was once a Wall Street darling, executing an inversion deal with Actavis and other aggressive acquisitions. As its growth prospects slowed, investors grew restless....
David Tepper’s Appaloosa hedge fund had been instigating for change
...A former Bausch & Lomb executive, the 49-year-old built Allergan through a succession of deals that began in 2013 when the company he ran, then called Actavis, bought Ireland-headquartered Warner Chilcott...
...The firm’s original investment in Allergan was a money-spinner, reaping gains of $2.3bn before the company agreed a sale to Actavis....
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...Allergan received a 10 per cent stake, or 100m shares, in Teva last year after it agreed to sell its generics business Actavis to the Israeli drugmaker last year....
...The relevant SEC filings were made by Allergan, Inc. prior to its acquisition by Actavis plc....
...The closely watched case not only opens up the medicine to more competition in the UK, but tests the ability of pharmaceuticals companies to defend patents for “secondary uses” after they lose market exclusivity...
...At Allergan, however, he said he was “very supportive” of Mr Saunders, a powerful player in the pharmaceuticals industry’s recent frenzy of dealmaking....
...In 2013 Ireland-based Warner Chilcott bought US-based Actavis, then in 2015, Actavis bought US-based Allergan....
...Allergan, previously known as Actavis, was itself one of numerous lesser-known US companies to have “redomiciled” to Ireland or other lower-tax countries....
...That transaction transformed the company, then known as Actavis, from a manufacturer of generic copycat medicines into a branded drugmaker. “Brent is a bold guy,” says one investor....
...Dechra Pharmaceuticals, the veterinary medicines maker, was down 3.7 per cent to £11.34 after Jefferies restarted coverage with “hold” advice....
...In 2013, US-based Actavis bought Ireland-headquartered Warner Chilcott, paving the way for the company to relocate its tax base away from the US and paved the way for a series of aggressive acquisitions...
...In 2013, US-based Actavis bought Ireland-headquartered Warner Chilcott, paving the way for the company to relocate its tax base away from the US and leading to aggressive acquisitions that culminated in...
...If you believe big pharmaceutical companies are inherently awful at research, it may be worth it....
...The tie-up with Actavis also paved the way for further dealmaking....
...This model appears to be that of an investment company trading pharmaceuticals businesses....
...Tim Powell, partner at Powell Gilbert, the law firm that represented Actavis, said the UK ruling provided “welcome clarity in a very complex area of the law”....
...The marriage between the makers of Viagra and Botox would, if consummated, create the world’s biggest pharmaceuticals group....
...Luckily for Teva Pharmaceutical it had a choice. On Monday Teva, a leading generic drugmaker, announced the $40.5bn acquisition of the generics unit of Allergan (formerly known as Actavis)....
...Others include Actavis, which bought Allergan, the maker of Botox, last year for $66bn and has since adopted the Allergan name....
...It is just over a year since Brent Saunders became chief executive of Allergan, then known as Actavis, but he has changed the company beyond recognition....
International Edition